4.2 Article

Perioperative Management of Patients with Glioblastoma

期刊

NEUROSURGERY CLINICS OF NORTH AMERICA
卷 32, 期 1, 页码 1-8

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.nec.2020.09.005

关键词

Glioblastoma; Awake brain surgery; Temozolamide

资金

  1. Mayo Clinic Professorship
  2. Clinician Investigator award
  3. Florida State Department of Health Research Grant
  4. Mayo Clinic Graduate School
  5. National Institutes of Health [R43CA221490, R01CA200399, R01CA195503, R01CA216855]

向作者/读者索取更多资源

In glioblastoma surgery, a statistically significant prognostic advantage starts at a volumetric resection level of 70% to 78% and increases steadily towards 100%, but complete resection is not always achievable due to the tumor's infiltrative nature. The goal of surgery is to achieve maximal resection with minimal morbidity, which can be done through various strategies such as intraoperative MRI, DTI, 5-ALA, and awake continuous mapping. A multidisciplinary team is necessary for the complex perioperative care needed for glioblastoma patients.
In GBM, statistically significant prognostic advantage begins at a level of volumetric resection of 70% to 78% and steadily increases as it approaches 100%. Because of its infiltrative nature, it is not always possible to achieve gross total resection while preserving neurologic function. Obtaining maximal resection with the least amount of morbidity is the goal of surgery. Several strategies can be used to achieve this goal, including IMRI, DTI, 5-ALA, and performing the surgery with the patient awake and continuous mapping. Given the complexity of the care needed for the perioperative management of patients with GBM, a multidisciplinary team is needed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据